Notice of Application - 2010
FR Doc 2010-21772[Federal Register: September 1, 2010 (Volume 75, Number 169)]
[Notices]
[Page 53721-53722]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01se10-101]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on May 4, 2010, Cambrex Charles
City, Inc., 1205 11th Street, Charles City, Iowa 50616, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedule II:
| Drug |
Schedule |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Lisdexamfetamine (1205) |
II |
| Methylphenidate (1724) |
II |
| Phenylacetone (8501) |
II |
| Codeine (9050) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Raw Opium (9600) |
II |
| Opium extracts (9610) |
II |
| Opium, powdered (9639) |
II |
| Opium, granulated (9640) |
II |
| Poppy Straw (9650) |
II |
| Oxymorphone (9652) |
II |
| Concentrate of Poppy Straw (9670) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture the listed controlled substances
in bulk for sale to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than November 1, 2010.
[[Page 53722]]
Dated: August 2, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-21772 Filed 8-31-10; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
